Roberta Prinapori

484 total citations
24 papers, 311 citations indexed

About

Roberta Prinapori is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Roberta Prinapori has authored 24 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Roberta Prinapori's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Roberta Prinapori is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (7 papers). Roberta Prinapori collaborates with scholars based in Italy, United States and France. Roberta Prinapori's co-authors include Antonio Di Biagio, Claudio Viscoli, Olivier Lortholary, Barry D. Brause, Saad J. Taj‐Aldeen, Valérie Zeller, Dimitrios P. Kontoyiannis, Blandine Rammaert, Emmanuel Roilides and Nikolaos V. Sipsas and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes and Epidemiology and Infection.

In The Last Decade

Roberta Prinapori

23 papers receiving 302 citations

Peers

Roberta Prinapori

EPIDE

VIROL

SURGE

ONCOL

Ruedi Luethy Switzerland

Concepció Figueras Spain

Jérôme Guinard France

Paola Tatarelli Italy

José Ramón Paño Spain

Cristina Roca-Oporto Spain

Robin Dretler United States

Jillian S. Y. Lau Australia

Chun-Yuan Lee Taiwan

Robert Yarrish United States

Ruedi Luethy Switzerland

Roberta Prinapori

114 ×0.5

185 ×1.3

EPIDE

28 ×0.4

VIROL

36 ×0.8

SURGE

13 ×0.4

ONCOL

Citations per year, relative to Roberta Prinapori Roberta Prinapori (= 1×) peers Ruedi Luethy

Countries citing papers authored by Roberta Prinapori

Since Specialization

Citations

This map shows the geographic impact of Roberta Prinapori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Prinapori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Prinapori more than expected).

Fields of papers citing papers by Roberta Prinapori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Prinapori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Prinapori. The network helps show where Roberta Prinapori may publish in the future.

Co-authorship network of co-authors of Roberta Prinapori

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Prinapori. A scholar is included among the top collaborators of Roberta Prinapori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Prinapori. Roberta Prinapori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boni, Silvia, Marina Sartini, Filippo Del Puente, et al.. (2024). Innovative Approaches to Monitor Central Line Associated Bloodstream Infections (CLABSIs) Bundle Efficacy in Intensive Care Unit (ICU): Role of Device Standardized Infection Rate (dSIR) and Standardized Utilization Ratio (SUR)—An Italian Experience. Journal of Clinical Medicine. 13(2). 396–396. 1 indexed citations

Parisini, Andrea, Silvia Boni, Filippo Del Puente, et al.. (2023). Impact of the COVID-19 Pandemic on Epidemiology of Antibiotic Resistance in an Intensive Care Unit (ICU): The Experience of a North-West Italian Center. Antibiotics. 12(8). 1278–1278. 8 indexed citations

Piras, Fabio, Roberta Prinapori, Maria Luisa Cristina, et al.. (2023). The Clinical Efficacy of Multidose Oritavancin: A Systematic Review. Antibiotics. 12(10). 1498–1498. 13 indexed citations

Prinapori, Roberta, Barbara Giannini, Niccolò Riccardi, et al.. (2018). Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy. Epidemiology and Infection. 146(5). 606–611. 10 indexed citations

Cento, Valeria, Ennio Polilli, Raffaella Cascella, et al.. (2015). May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics.. PubMed. 38(4). 491–7. 1 indexed citations

Sticchi, Laura, Antonio Di Biagio, Marina Sartini, et al.. (2015). Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.. PubMed. 38(4). 499–509.

Delfino, Emanuele, et al.. (2015). Disseminated Histoplasmosis with Mucocutaneous Immune Reconstitution Inflammatory Syndrome in an HIV-Infected Patient. AIDS Research and Human Retroviruses. 31(3). 274–275. 5 indexed citations

Biagio, Antonio Di, Alessandro Cozzi‐Lepri, Roberta Prinapori, et al.. (2015). Discontinuation of Initial Antiretroviral Therapy in Clinical Practice. JAIDS Journal of Acquired Immune Deficiency Syndromes. 71(3). 263–271. 31 indexed citations

Prinapori, Roberta, Laura Sticchi, Cristiano Alicino, et al.. (2015). Role of HCV-RNA decay and IP-10 levels after 48 hours of standard HCV therapy as predictors of rapid virological response. Clinics and Research in Hepatology and Gastroenterology. 39(6). 705–710. 1 indexed citations

10.

Biagio, Antonio Di & Roberta Prinapori. (2015). Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS. Patient Preference and Adherence. 9. 1213–1213. 6 indexed citations

11.

Dentone, Chiara, Daniela Fenoglio, Eva Schenone, et al.. (2015). Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous system. HIV Clinical Trials. 16(5). 190–196. 8 indexed citations

12.

Biagio, Antonio Di, Alessandro Cozzi‐Lepri, Roberta Prinapori, et al.. (2014). Treatment discontinuation in HIV‐1‐infected individuals starting their first‐line HAART after 2008: data from the ICONA Foundation Study Cohort. Journal of the International AIDS Society. 17(4S3). 19825–19825. 4 indexed citations

13.

Gamaletsou, Maria N., Blandine Rammaert, Brad Moriyama, et al.. (2014). Aspergillus osteomyelitis: Epidemiology, clinical manifestations, management, and outcome. Journal of Infection. 68(5). 478–493. 83 indexed citations

14.

Biagio, Antonio Di, Roberta Prinapori, Lucia Taramasso, et al.. (2014). Which Patients have Greatest Need for Elvitegravir/Cobicistat/ Emtricitabine/TenofovirDF-Based Therapy?. Recent Patents on Anti-Infective Drug Discovery. 9(1). 41–51. 2 indexed citations

15.

Gagliardini, Roberta, Barbara Rossetti, Cláudia Bianco, et al.. (2014). Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study. Journal of the International AIDS Society. 17(4S3). 19818–19818. 10 indexed citations

16.

Rammaert, Blandine, Maria N. Gamaletsou, Valérie Zeller, et al.. (2014). Dimorphic fungal osteoarticular infections. European Journal of Clinical Microbiology & Infectious Diseases. 33(12). 2131–2140. 29 indexed citations

17.

Biagio, Antonio Di, Bianca Bruzzone, Laura Sticchi, et al.. (2013). Use of raltegravir in a late presenter HIV-1 woman in advanced gestational age: case report and literature review. Journal of Chemotherapy. 25(3). 181–183. 12 indexed citations

18.

Prinapori, Roberta, Antoine Khalil, Hervé Lécuyer, et al.. (2012). Risk associated with a systematic search of extended-spectrum β-lactamase–producing Enterobacteriaceae. American Journal of Infection Control. 41(3). 259–260. 7 indexed citations

19.

Biagio, Antonio Di, Roberta Prinapori, Diana Giannarelli, et al.. (2012). Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. Journal of Antimicrobial Chemotherapy. 68(1). 200–205. 11 indexed citations

20.

Mikulska, Małgorzata, Valerio Del Bono, Roberta Prinapori, et al.. (2010). Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. Transplant Infectious Disease. 12(6). 505–512. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact